Alberta has stopped administering first doses of Oxford-AstraZeneca’s COVID-19 vaccine, except in limited cases, becoming the only government in Canada to make such a move as other provinces weigh their options with remaining doses of the vaccine.
The change is being made both because Canada has the luxury of relying on two other shots for its mass vaccination campaign but also because of the safety concerns of a very rare but serious side effect associated with AstraZeneca. Viral vector vaccines, like those from AstraZeneca and Johnson & Johnson, are linked to a blood-clot condition that mRNA vaccines, from Pfizer-BioNTech and Moderna, are not connected to. (not entirely true regarding the mRNA jabs)
Ontario’s Chief Medical Officer of Health, David Williams, said Monday that the province is reviewing the use of the AstraZeneca vaccine. He and his counterparts in other provinces are still trying to sort out the “right balance” between the risks posed by the vaccine and the risks of COVID-19.
Sorting out the right balance? Very clearly the authorities have been lying all along about the benefit of the vaccines outweighing the risk if they now have to "sort out the right balance"
According to Britain’s drug regulator, the incidence of the syndrome, called vaccine-induced immune thrombotic thrombocytopenia (VITT), is about one in 100,000. But other studies in Europe put the incidence at one in 26,000. The Public Health Agency of Canada said the estimated rate is evolving but as of April 28, the rate of VITT in Canada was one case for every 100,000 people vaccinated with AstraZeneca.
* 2.3 million jabs in Canada have been with AstraZeneca
Canada is claiming 1 VITT for every 100,000 with 3 dead. Which means we have to have at least 23 cases of VITT right now in Canada- There's that dishonesty again...
So far, 12 cases of VITT have been reported by the provinces, and three people have died as a result, spokesperson Anna Maddison said.